PXD069074 is an
original dataset announced via ProteomeXchange.
Dataset Summary
| Title | Lung adenocarcinoma surfaceome remodeling with EGFR inhibitors uncovers placental alkaline phosphatase as a target for combination therapy |
| Description | Treatment of lung adenocarcinomas (LUAD) that exhibit activated epidermal growth factor receptor (EGFR) with EGFR tyrosine kinase inhibitors (TKI) has limited efficacy. Assessment of the impact of EGFR TKI on the LUAD surfaceome remodeling revealed potential therapeutic targets. We identified placental type alkaline phosphatase (ALPP) which has restricted expression in normal tissues, among upregulated surface proteins following EGFR TKI treatment of both TKI sensitive as well as resistant cells. Upregulation of ALPP with EGFR TKI resulted from activation of FoxO3a. The combination of EGFR TKI plus ALPP antibody conjugated with monomethylauristatin F enhanced tumor killing in osimertinib-sensitive and osimertinib-resistant LUAD models compared to either treatment alone. Our findings point to surfaceome remodeling induced with an established cancer therapy as a means for the development of more effective combination therapies. |
| HostingRepository | PRIDE |
| AnnounceDate | 2025-10-09 |
| AnnouncementXML | Submission_2025-10-09_10:13:31.171.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | Yining Cai |
| SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: NEWT:9606; |
| ModificationList | monohydroxylated residue; iodoacetamide derivatized residue |
| Instrument | Bruker Daltonics timsTOF series |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
| 0 | 2025-10-02 04:05:37 | ID requested | |
| ⏵ 1 | 2025-10-09 10:13:31 | announced | |
Publication List
| Dataset with its publication pending |
Keyword List
| submitter keyword: Placental type alkaline phosphatase, EGFR Tyrosine kinase inhibitors, Antibody drug conjugate, EGFR TKI resistance,Lung adenocarcinomas, Combinational therapy |
Contact List
| Samir Hanash |
| contact affiliation | Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. |
| contact email | shanash@mdanderson.org |
| lab head | |
| Yining Cai |
| contact affiliation | Software Developer |
| contact email | ycai4@mdanderson.org |
| dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/10/PXD069074 |
| PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD069074
- Label: PRIDE project
- Name: Lung adenocarcinoma surfaceome remodeling with EGFR inhibitors uncovers placental alkaline phosphatase as a target for combination therapy